Canine fibroblast growth factor receptor 3 sequence is conserved across dogs of divergent skeletal size

Logan B. Smith, Danika L Bannasch, Amy E. Young, Deborah I. Grossman, Janelle M. Belanger, Anita M. Oberbauer

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Background: Fibroblast growth factor receptor 3 (FGFR3) is expressed in the growth plate of endochondral bones and serves as a negative regulator of linear bone elongation. Activating mutations severely limit bone growth, resulting in dwarfism, while inactivating mutations significantly enhance bone elongation and overall skeletal size. Domesticated dogs exhibit the greatest skeletal size diversity of any species and, given the regulatory role of FGFR3 on growth plate proliferation, we asked whether sequence differences in FGFR3 could account for some of the size differences. Methods: All exons, the promoter region, and 60 bp of the 3' flanking region of the canine FGFR3 gene were sequenced for nine different dog breeds representing a spectrum of skeletal size. The resultant sequences were compared to the reference Boxer genome sequence. Results: There was no variation in sequence for any FGFR3 exons, promoter region, or 3′ flanking sequence across all breeds evaluated. Conclusion: The results suggest that, regardless of domestication selection pressure to develop breeds having extreme differences in skeletal size, the FGFR3 gene is conserved. This implies a critical role for this gene in normal skeletal integrity and indicates that other genes account for size variability in dogs.

Original languageEnglish (US)
Article number67
JournalBMC Genetics
Volume9
DOIs
StatePublished - Oct 21 2008

Fingerprint

Receptor, Fibroblast Growth Factor, Type 3
Conserved Sequence
Canidae
Dogs
3' Flanking Region
Growth Plate
Genetic Promoter Regions
Bone and Bones
Genes
Exons
Dwarfism
Mutation
Bone Development
Genome
Pressure

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Cite this

Canine fibroblast growth factor receptor 3 sequence is conserved across dogs of divergent skeletal size. / Smith, Logan B.; Bannasch, Danika L; Young, Amy E.; Grossman, Deborah I.; Belanger, Janelle M.; Oberbauer, Anita M.

In: BMC Genetics, Vol. 9, 67, 21.10.2008.

Research output: Contribution to journalArticle

Smith, Logan B. ; Bannasch, Danika L ; Young, Amy E. ; Grossman, Deborah I. ; Belanger, Janelle M. ; Oberbauer, Anita M. / Canine fibroblast growth factor receptor 3 sequence is conserved across dogs of divergent skeletal size. In: BMC Genetics. 2008 ; Vol. 9.
@article{8c52d3b9b1c14d25933db8159f3c3b05,
title = "Canine fibroblast growth factor receptor 3 sequence is conserved across dogs of divergent skeletal size",
abstract = "Background: Fibroblast growth factor receptor 3 (FGFR3) is expressed in the growth plate of endochondral bones and serves as a negative regulator of linear bone elongation. Activating mutations severely limit bone growth, resulting in dwarfism, while inactivating mutations significantly enhance bone elongation and overall skeletal size. Domesticated dogs exhibit the greatest skeletal size diversity of any species and, given the regulatory role of FGFR3 on growth plate proliferation, we asked whether sequence differences in FGFR3 could account for some of the size differences. Methods: All exons, the promoter region, and 60 bp of the 3' flanking region of the canine FGFR3 gene were sequenced for nine different dog breeds representing a spectrum of skeletal size. The resultant sequences were compared to the reference Boxer genome sequence. Results: There was no variation in sequence for any FGFR3 exons, promoter region, or 3′ flanking sequence across all breeds evaluated. Conclusion: The results suggest that, regardless of domestication selection pressure to develop breeds having extreme differences in skeletal size, the FGFR3 gene is conserved. This implies a critical role for this gene in normal skeletal integrity and indicates that other genes account for size variability in dogs.",
author = "Smith, {Logan B.} and Bannasch, {Danika L} and Young, {Amy E.} and Grossman, {Deborah I.} and Belanger, {Janelle M.} and Oberbauer, {Anita M.}",
year = "2008",
month = "10",
day = "21",
doi = "10.1186/1471-2156-9-67",
language = "English (US)",
volume = "9",
journal = "BMC Genetics",
issn = "1471-2156",
publisher = "BioMed Central",

}

TY - JOUR

T1 - Canine fibroblast growth factor receptor 3 sequence is conserved across dogs of divergent skeletal size

AU - Smith, Logan B.

AU - Bannasch, Danika L

AU - Young, Amy E.

AU - Grossman, Deborah I.

AU - Belanger, Janelle M.

AU - Oberbauer, Anita M.

PY - 2008/10/21

Y1 - 2008/10/21

N2 - Background: Fibroblast growth factor receptor 3 (FGFR3) is expressed in the growth plate of endochondral bones and serves as a negative regulator of linear bone elongation. Activating mutations severely limit bone growth, resulting in dwarfism, while inactivating mutations significantly enhance bone elongation and overall skeletal size. Domesticated dogs exhibit the greatest skeletal size diversity of any species and, given the regulatory role of FGFR3 on growth plate proliferation, we asked whether sequence differences in FGFR3 could account for some of the size differences. Methods: All exons, the promoter region, and 60 bp of the 3' flanking region of the canine FGFR3 gene were sequenced for nine different dog breeds representing a spectrum of skeletal size. The resultant sequences were compared to the reference Boxer genome sequence. Results: There was no variation in sequence for any FGFR3 exons, promoter region, or 3′ flanking sequence across all breeds evaluated. Conclusion: The results suggest that, regardless of domestication selection pressure to develop breeds having extreme differences in skeletal size, the FGFR3 gene is conserved. This implies a critical role for this gene in normal skeletal integrity and indicates that other genes account for size variability in dogs.

AB - Background: Fibroblast growth factor receptor 3 (FGFR3) is expressed in the growth plate of endochondral bones and serves as a negative regulator of linear bone elongation. Activating mutations severely limit bone growth, resulting in dwarfism, while inactivating mutations significantly enhance bone elongation and overall skeletal size. Domesticated dogs exhibit the greatest skeletal size diversity of any species and, given the regulatory role of FGFR3 on growth plate proliferation, we asked whether sequence differences in FGFR3 could account for some of the size differences. Methods: All exons, the promoter region, and 60 bp of the 3' flanking region of the canine FGFR3 gene were sequenced for nine different dog breeds representing a spectrum of skeletal size. The resultant sequences were compared to the reference Boxer genome sequence. Results: There was no variation in sequence for any FGFR3 exons, promoter region, or 3′ flanking sequence across all breeds evaluated. Conclusion: The results suggest that, regardless of domestication selection pressure to develop breeds having extreme differences in skeletal size, the FGFR3 gene is conserved. This implies a critical role for this gene in normal skeletal integrity and indicates that other genes account for size variability in dogs.

UR - http://www.scopus.com/inward/record.url?scp=55249083993&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=55249083993&partnerID=8YFLogxK

U2 - 10.1186/1471-2156-9-67

DO - 10.1186/1471-2156-9-67

M3 - Article

C2 - 18940000

AN - SCOPUS:55249083993

VL - 9

JO - BMC Genetics

JF - BMC Genetics

SN - 1471-2156

M1 - 67

ER -